Symlin pramlintide: AMLN began a placebo-controlled Phase III safety study in up to 250 patients with Type 1 diabetes. The trial will include a 1 month Symlin d

Amylin Pharmaceuticals Inc. (AMLN), San Diego, Calif. Product: Symlin pramlintide Business: Metabolic Therapeutic category: Metabolism Target: Amylin receptors Description: Synthetic analog of amyli...